Is Vascepa Available in Smaller Quantities?
Vascepa (icosapent ethyl) comes in 1-gram capsules, typically dispensed in bottles of 120 or 240 capsules, or as 4-capsule blister packs for single-use convenience.[1] Smaller quantities like 30- or 60-capsule bottles are not standard from the manufacturer, Amarin Pharma, but some pharmacies and mail-order services offer them through custom filling or partial bottle dispensing to reduce upfront costs for patients.[2]
How Do You Get Smaller Supplies from Pharmacies?
Retail chains like CVS, Walgreens, and Costco often split larger bottles into 30- or 90-day supplies if requested, especially with prior authorization for cost-saving. Online pharmacies such as GoodRx or Amazon Pharmacy list 120-capsule bottles but allow quantity adjustments down to 60 capsules via their platforms, with prices around $300-$400 for 60 capsules (cash price, varying by location).[3][4] Check with your insurer, as copays may apply differently for partial fills.
Why Might Smaller Quantities Cost More per Capsule?
Unit prices rise for smaller packs—e.g., $4-$5 per capsule for 60-count vs. $2-$3 for 240-count—due to packaging, dispensing fees, and lack of bulk discounts. Patient assistance programs from Amarin (vascepasupport.com) provide free or low-cost supplies for eligible uninsured patients, often in starter packs of 120 capsules, but not smaller trial sizes.[5]
What Are Alternatives for Lower-Dose or Smaller Purchases?
No official lower-dose Vascepa exists (it's fixed at 4g daily for most uses), but generic icosapent ethyl, approved in 2024, matches the same pack sizes and is cheaper overall—potentially available in smaller quantities soon as uptake grows.[6] Over-the-counter fish oil capsules offer smaller daily doses but lack Vascepa's purified EPA benefits for cardiovascular risk reduction. For trials, doctors sometimes prescribe 30-day starter packs.
When Does Vascepa's Patent Expire, Affecting Generic Options?
Key patents on Vascepa's formulation and use expire between 2033 (method-of-use) and 2039 (core compound), with generics like Dr. Reddy's entering in late 2024 after settlements.[1] This delays widespread small-quantity generics but opens competition soon. DrugPatentWatch.com tracks these: Vascepa Patents.[1]
[1]: DrugPatentWatch.com - Vascepa
[2]: Amarin Pharma - Vascepa Prescribing Info
[3]: GoodRx - Vascepa Prices
[4]: Amazon Pharmacy - Vascepa
[5]: Vascepa Savings Program
[6]: FDA - Icosapent Ethyl Approvals